How to Onboard a New Cleanroom Mop Supplier — A GMP Implementation Guide

A single-product, single-grade transition can typically be completed in 4 weeks, assuming pre-onboarding preparation is complete before Week 1 starts and samples are available without delay. Multi-product or multi-grade transitions will take longer. The most common cause of timeline extension is incomplete documentation from the supplier in Week 1 — which is why documentation review should be the first gate check.

In a GMP facility, yes — changing a cleaning tool that contacts critical surfaces should be managed through the change control process. The change control record should document the rationale for the change, the testing protocol and results, the updated SOPs, operator training records, and the parallel run data supporting the go-live decision. Opening the change control record early (before testing begins) allows the evaluation framework to be reviewed and approved upfront, which can streamline the final approval.

At minimum: Certificate of Analysis (COA) with lot-specific test data, Certificate of Conformance (CoC), material composition declaration, particle generation data with test method reference, chemical compatibility data, and dimensional specifications. For sterile products: Certificate of Irradiation (CoI) with dose data, sterility assurance documentation, and packaging integrity documentation. All documents should be traceable to the specific lots being tested. If a supplier cannot provide these documents during onboarding, they are unlikely to provide them consistently after becoming the primary supplier.

A performance difference is not necessarily a failure — it depends on whether the difference is acceptable within your acceptance criteria. If the new product absorbs less disinfectant but still meets coverage requirements, the change may be acceptable with a SOP adjustment to re-saturate more frequently. If the difference is outside acceptance criteria, document the finding, share it with the supplier, and either request product adjustment or return to your supplier shortlist. The purpose of testing is not to confirm that the new product is identical to the old — it is to confirm that it performs within your facility’s requirements.

Yes — running a dual-source supply model is a valid supply chain strategy, particularly for higher-risk sterile consumables. However, dual sourcing increases the documentation and change control burden: both suppliers require separate qualification records, separate incoming inspection protocols, and separate change notification monitoring. The quality agreement with each supplier should clearly define documentation expectations. Some facilities dual-source higher-grade products (Grade A/B) and single-source lower-grade products (Grade C/D) as a risk-based approach.

The most common reason is a documentation gap discovered during Week 1 that cannot be resolved. A supplier that provides a generic COA without lot-specific data, or a CoI without dose information, may pass a high-level audit questionnaire but fail the detailed documentation review that occurs during onboarding. This is why the documentation gate check is critical: it reveals the difference between a supplier who says they provide documentation and a supplier who actually provides audit-grade documentation.

Onboarding requires coordination across QA, Procurement, and Cleanroom Management. QA typically owns documentation review and testing protocol approval. Procurement manages the supplier relationship and quality agreement. Cleanroom Management owns SOP updates and operator training. A single project owner — often a QA lead or Procurement manager — should coordinate the overall timeline and gate checks. Without a designated owner, onboarding tasks can fall between departmental responsibilities and extend the timeline significantly.